Avadel Pharmaceuticals (AVDL) Net Income: 2009-2021
Historic Net Income for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -$85.5 million.
- Avadel Pharmaceuticals' Net Income fell 894.24% to -$23.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$88.2 million, marking a year-over-year decrease of 514.63%. This contributed to the annual value of -$85.5 million for FY2021, which is 1253.58% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Net Income of -$85.5 million as of FY2021, which was down 1,253.58% from -$6.3 million recorded in FY2020.
- In the past 5 years, Avadel Pharmaceuticals' Net Income registered a high of $68.3 million during FY2017, and its lowest value of -$95.3 million during FY2018.
- Moreover, its 3-year median value for Net Income was -$76.0 million (2019), whereas its average is -$56.0 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Net Income skyrocketed by 265.40% in 2017, and later tumbled by 1,253.58% in 2021.
- Avadel Pharmaceuticals' Net Income (Yearly) stood at $68.3 million in 2017, then slumped by 239.60% to -$95.3 million in 2018, then grew by 20.22% to -$76.0 million in 2019, then spiked by 91.69% to -$6.3 million in 2020, then crashed by 1,253.58% to -$85.5 million in 2021.